Navigation Links
Precision Therapeutics President and CEO Sean McDonald Named Ernst & Young Entrepreneur of the Year(R) 2008 Regional Award Winner
Date:7/2/2008

PITTSBURGH, July 2 /PRNewswire/ -- Precision Therapeutics today announced that its President and Chief Executive Officer Sean McDonald received the Ernst & Young Entrepreneur of the Year(R) 2008 Award in the Applied Science category in the Upstate New York, Western Pennsylvania and West Virginia region. This award recognizes outstanding entrepreneurs who are building and leading dynamic growth businesses. McDonald was selected by an independent panel of judges and the award was presented at an Ernst & Young Entrepreneur of the Year gala event at the Carnegie Music Hall in Pittsburgh on Friday, June 27, 2008.

"Being named an Ernst & Young Entrepreneur of the Year is a great honor for me and my team as we work towards our goal of improving the lives of people living with cancer," said McDonald. "This is not only a win for Precision; it is also a win for the growing life science industry in the Pittsburgh region."

Sean joined Precision Therapeutics in 2001 and serves as President and CEO. Prior to joining Precision, Sean founded Automated Healthcare in 1992, developing the first robotics-based solution to hospital pharmacy management. Automated Healthcare was successfully acquired by McKesson Corporation in 1996. In addition to his current award, Sean has been recognized with a 1999 Ernst & Young Entrepreneur of the Year Award, a 1999 Carnegie Award for Excellence in Science and Technology, the Smithsonian Institution Award for heroic achievement in information technology, and the Pittsburgh Life Sciences Greenhouse 2004 PIONEER award. Sean received a BS in Engineering from the University of Pennsylvania and an MS in Electrical Engineering and Computer Science from the University of Florida.

About Precision Therapeutics

Precision Therapeutics is a diagnostics services company dedicated to providing physicians and patients with actionable clinical information to personalize cancer treatments. Precision's ChemoFx(R) test measures an ind
'/>"/>

SOURCE Precision Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Applied Precision Announces Sale of Life Sciences Business Unit to Senior Management and Telegraph Hill Partners
2. Precision Therapeutics Adds 8 Million Covered Lives Under Contract
3. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Mutually Terminate Merger Agreement; Oracle Healthcare Acquisition Corp. Cancels Special Meeting
4. Oracle Healthcare Acquisition Corp. and Precision Therapeutics, Inc. Agree in Principle to Amend Merger Agreement to Reduce Consideration by 15%
5. Precision Optics Corporation Announces First Quarter Results and Receipt of Significant New Order
6. New Generation Xcelodose(R)S Precision Drug Powder Micro-filling System Offers 50% Increased Throughput
7. Varian Medical Systems to Unveil RapidArc(TM) Volumetric Arc Therapy and Other Products Designed to Speed Delivery of Precision Radiotherapy and Brachytherapy
8. Precision Optics Corporation Announces Fourth Quarter and Year End Results With Highest Revenues in Six Years
9. 2008 International Federation of Adipose Therapeutics and Science (IFATS) Conference Date Set
10. Jerry Steffl Joins Prime Therapeutics as Vice President, Government Affairs
11. Fischman receives Pharmacology/Therapeutics/Toxicology Research Award
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2015)... ... August 01, 2015 , ... “ reTXT ” was featured on NewsWatch as ... applications on the market for iOS, Android, and Windows. Joe Toohey, the host of ... to clarify, edit and delete any message including ones already sent. , While text ...
(Date:7/31/2015)... , ... July 31, 2015 , ... ... Times magazine. What are the STASH awards? The Significant Technological Achievements in ... the cannabis-cultivation community as well as tried-and-true products that have stood the test ...
(Date:7/31/2015)... (PRWEB) , ... July 31, 2015 , ... When the ... stuff, Super-Sod debuted their new type of sod called Leisure Time(TM) zoysia . ... in process. , To commemorate introduction of this new type of sod, Super-Sod is ...
(Date:7/31/2015)... ... 2015 , ... Super Bowl 50 will emanate from Levi’s Stadium in Santa Clara, ... is the Super Bowl. In the two weeks that separate the conference championships and the ... 2016 Super Bowl game will mark the 50th time it has been held and the ...
(Date:7/31/2015)... ... 2015 , ... Precision Aesthetics is New York’s only Thermage skin tightening pinnacle ... provider of Exilis non-surgical fat reduction in New York. Due to its unparalleled ... International clientele. Many patients travel to New York to get their non-surgical skin ...
Breaking Medicine News(10 mins):Health News:Correct Auto-Correct and Clarify the Unclear with reTXT Messaging App 2Health News:The High Times S.T.A.S.H. Awards Are in, Guess Who Took Home the Prize for “Best Grow System” 2Health News:Super-Sod Introduces Leisure Time(TM) Zoysia Grass with an Adirondack Chair Promotion 2Health News:Cheap 2016 Super Bowl Tickets at Levi's Stadium: Ticket Down Slashes Ticket Prices on Super Bowl 50 Tickets in Santa Clara, CA at Levi's Stadium 2
... , , ... first roundtable of Health and Tourism ministerial delegates came ... the steps required to give it the necessary thrust. ... the high-powered congregation of senior ministers and policy makers ...
... unclear , WEDNESDAY, Dec. 2 (HealthDay News) -- New ... germs, including bacteria that cause respiratory disease. , But as ... of the new study aren,t sure what, if any, hazard ... Microbes surround us every day of our lives. , ...
... not be able to tell a good book by its ... old book by its smell. In a report in ACS, ... of a new test that can measure the degradation of ... The nondestructive "sniff" test could help libraries and museums preserve ...
... Dec. 2 Holly Potter, vice president, Public Relations, National ... Team Leader" award at PR News, PR People ... PR News, PR People Awards competition showcases the ... are making communications matter in the marketplace. The winners of ...
... , Media Advisory for Thursday, Dec. ... to Speak at Luncheon Meeting of Army Wounded Warriors; Army ... , WASHINGTON, Dec. 2 The following was released today ... Wounded veterans and career counselors from the Army Wounded Warrior ...
... could be linked to life span in males , WEDNESDAY, ... span in humans and other mammals and could help explain ... say. , The researchers found that mice created using two ... 186 days longer than mice created from the normal combination ...
Cached Medicine News:Health News:Ministerial Roundtable Discusses Future of Medical Tourism 2Health News:Ministerial Roundtable Discusses Future of Medical Tourism 3Health News:Smokers Inhaling Germs With Each Cigarette 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 2Health News:Kaiser Permanente Public Relations Leader Wins PR People Award 3Health News:Wounded Vets, CAREER Counselors Gather in Washington as Obama Announces Afghanistan Troop Buildup 2Health News:Sperm Gene May Cause Men's Longevity Disadvantage 2
(Date:7/30/2015)... Calif. , July 30, 2015  EP ... /Alcon executives have recently contacted the Company about ... begin as early as Monday, August 3, 2015.  ... quoted as saying that the coming electronic contact ... of dollars over the next several years.  Novartis ...
(Date:7/30/2015)... THOUSAND OAKS, Calif., July 30, 2015  Amgen ... for the second quarter of 2015. Key results ... versus the second quarter of 2014 to $5,370 ... primarily by Enbrel ® (etanercept), Prolia ® ... (carfilzomib) and XGEVA ® (denosumab). Unfavorable ...
(Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... 2015 keynote address last month that industry is compelled ... order to gain the efficiencies—and develop the transformational innovations ... Dr. Barsoum,s comments were preceded by Doug Kohrs ... and OMTEC moderator, who stressed that industry must add ...
Breaking Medicine Technology:Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 2Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 3Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 4Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 5Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 6Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 7Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 8Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 9Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 10Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 11Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 12Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 13Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 14Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 15Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 16Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 17Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 18Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 19Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 20Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 21Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 22Amgen's Second Quarter 2015 Revenues Increased 4 Percent To $5.4 Billion And Adjusted Earnings Per Share (EPS) Increased 8 Percent To $2.57 23Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2
... , NATICK, Mass., Dec. 10 Boston Scientific Corporation (NYSE: ... of $2 billion aggregate principal amount of its senior notes under ... $850 million of 4.50 percent notes due January 2015, $850 million ... 7.375 percent notes due January 2040. The Company expects the ...
... , SAN ANTONIO, Dec. 10 Genomic ... The Lancet Oncology published positive results from a study ... estrogen receptor-positive breast cancer conducted by the Southwest Oncology Group ... The Lancet Oncology published these results ...
Cached Medicine Technology:Boston Scientific Announces Pricing of $2 Billion of Senior Notes 2Boston Scientific Announces Pricing of $2 Billion of Senior Notes 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5
... surgeon and O.R. staff work hard to ... fluid intravasation. Manual methods are complicated, time-consuming, ... DOLPHIN II Fluid Management System for hysteroscopy, ... endoscopic irrigation. It has been developed to ...
... These 3mL PYREX volumetric pipets ... tolerances in accordance with ASTM ... pipet is individually serialized and ... Identification and Capacity, traceable to ...
... 4mL PYREX volumetric pipets are ... (TC - bottom line) and ... line) to specifications for Class ... color-coded with colored graduations and ...
1000L...
Medicine Products: